Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Maverix, $100,000 Order from University of Missouri For 99 Lives Cat Whole Genome Sequencing Initiative

Published: Wednesday, January 29, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
Maverix Analytic Platform to be Used for Analysis and Hosting of Community of Discovery.

Maverix Biomics, Inc. is pleased to announce that it has received a $100,000 order from the University of Missouri for the analysis of feline genomes as part of the 99 Lives Cat Whole Genome Sequencing Initiative, a joint project between the University of Missouri, the University of California, Davis, and industrial partners. In addition, Maverix will be hosting the 99 Lives Cat Whole Genome
Sequencing Initiative genome and analysis data as a free, publicly-accessible “Community of Discovery.”


Communities of Discovery, established among scientists for a particular organism or common research area, are built on the cloud-based Maverix Analytic Platform that enables the simple sharing of data, accessible analytic workflows, and interactive browsing of results between groups of researchers. Researchers can distribute information privately or as broadly as desired; with colleagues at the same organization or around the world. These environments are ideal for international consortiums to cooperatively annotate new or existing genomes, with experts from around the world able to view and contribute new annotations interactively.


The 99 Lives Cat Whole Genome Sequencing Initiative is a project designed to sequence the genome of 99 cats in order to improve coverage and future assemblies of the cat genome; identify genotypic variation across a large number of cats with diverse genetic backgrounds, helping to identify causative mutations for specific health conditions; and increase the value of individual cat genome sequencing by veterinary hospitals providing state-of-the-art health care.

Sequencing and analyzing the genomes of 99 cats will enable researchers to better understand disease pathways and ultimately develop diagnostic and screening tests that will improve treatments. The first cat genome, derived from a single Abyssinian cat named Cinnamon, was released in 2007 with relatively low sequencing coverage. The much higher resolution sequencing across a cat population provided by the 99 Lives Initiative will produce a much richer public set of genome variants. An improved assembly of the reference cat genome is also due later this year, and will benefit from
incorporation of new data from the 99 Lives Initiative.


The University of Missouri is coordinating this project to ensure a variety of critical goals are met: the inclusion of cats from different breeds and geographic locations to maximize variation detection; the use of consistent methods to facilitate variant identification; uniform quality and wide public distribution of data; and a common analytic resource for colleagues new to genomics research and large scale bioinformatics.


"I am excited about the potential of the 99 Lives Initiative to lead to a better understanding of cat genetics, which ultimately will lead to advances in healthcare," said Leslie Lyons PhD, Gilbreath-McLorn Professor for Comparative Medicine at the University of Missouri-Columbia. "I look forward to Maverix Biomics' support of this project to ensure its success via accuracy, consistency, and continuity."


“We are pleased to support Professor Lyons, and the efforts of cat researchers worldwide, as they advance our knowledge of the cat genome,” said Dave Mandelkern, President and co-founder of Maverix Biomics. “Hosting the 99 Lives Initiative, and the approximately 168 terabytes of data associated with it, is another example of our commitment to open science and making data and analytic tools readily available to researchers through this Community of Discovery.”


Access to the 99 Lives Cat Whole Genome Sequencing Initiative public data sets and visualization of the data within the UCSC Genome Browser will be available at no cost to researchers. Adding additional data or performing new data analytics, exploration, or visualization is possible for additional fees, with substantial discounts for academic and not-for-profit research organizations. The Maverix “pay-as-you-go” pricing model means that researchers only pay for the additional resources they use, when they use them.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!